Sintx Technologies (SINT) Return on Capital Employed Growth (3y) (2017 - 2026)
Sintx Technologies (SINT) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | - |
| 10 | Sintx Technologies | 6.22 Mn | 4.33 Mn | 144,000.00 | -17,204.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,204.00 |
| Dec 31, 2025 | -7.00 |
| Sep 30, 2025 | -8,687.00 |
| Jun 30, 2025 | -8,871.00 |
| Mar 31, 2025 | -10,074.00 |
| Dec 31, 2024 | -11,617.00 |
| Sep 30, 2024 | -8,838.00 |
| Jun 30, 2024 | -5,080.00 |
| Mar 31, 2024 | -6,903.00 |
| Dec 31, 2023 | -7,692.00 |
| Sep 30, 2023 | -6,860.00 |
| Jun 30, 2023 | -3,142.00 |
| Mar 31, 2023 | -1,739.00 |
| Dec 31, 2022 | -7,545.00 |
| Sep 30, 2022 | -1,003.00 |
| Jun 30, 2022 | 6,951.00 |
| Mar 31, 2022 | 9,715.00 |
| Dec 31, 2021 | 7,247.00 |
| Sep 30, 2021 | 5,716.00 |
| Jun 30, 2021 | 5,618.00 |